Back to search results

A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa

Abroad (travel likely)RecruitingPHASE2

Conditions

Hidradenitis Suppurativa (HS)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Medical Dermatology Specialist, Phoenix, Arizona, United States

  • Accel Research Sites Network, Maitland, Florida, United States

  • Floridian Research Institute, Miami, Florida, United States

  • Cordova Research Institute, Miami, Florida, United States

  • Tory Sullivan MD PA - Dermatology, North Miami Beach, Florida, United States

  • MplusM - D&H Tamarac Research Center, Tamarac, Florida, United States

  • ForCare Clinical Research, Tampa, Florida, United States

  • Kentucky Advanced Medical Research LLC, Murray, Kentucky, United States

  • ActivMed Practices & Research, LLC, Portsmouth, New Hampshire, United States

  • Equity Medical, LLC, The Bronx, New York, United States

Study leads

  • Lara Pupim, MD, MSCI

    Study Director

    Navigator Medicines, Inc.

View source on ClinicalTrials.gov(opens in a new tab)